97-13447. Open Meeting for Representatives of Health Professional Organizations  

  • [Federal Register Volume 62, Number 99 (Thursday, May 22, 1997)]
    [Notices]
    [Page 28053]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-13447]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Open Meeting for Representatives of Health Professional 
    Organizations
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice of public meeting.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing an open 
    meeting with representatives of health professional organizations. The 
    meeting will be chaired by Sharon Smith Holston, Deputy Commissioner 
    for External Affairs. This meeting will provide participants an 
    opportunity to hear a discussion on prescription (Rx) to over-the-
    counter (OTC) switches and the new OTC proposed labeling initiative.
    
    DATES: The meeting will be held on Thursday, May 29, 1997, from 1:30 
    p.m. to 4:30 p.m.
    
    ADDRESSES: The meeting will be held at the Bethesda Holiday Inn, 8210 
    Wisconsin Ave., Bethesda, MD. Interested persons may register with 
    Betty Palsgrove at 301-443-1652. Registrations also may be transmitted 
    by FAX to 1-800-344-3332 or 301-443-2446.
    
    FOR FURTHER INFORMATION CONTACT: Peter H. Rheinstein, Office of Health 
    Affairs (HFY-40), Food and Drug Administration, 5600 Fishers Lane, 
    Rockville, MD 20857, 301-443-5470.
    
    SUPPLEMENTARY INFORMATION: The purpose of the meeting is to provide an 
    opportunity for representatives of health professional organizations 
    and other interested persons to be briefed by senior FDA staff and to 
    provide an opportunity for informal discussion on the switching of drug 
    products from prescription to OTC status and on FDA's proposed 
    regulation for labeling of OTC drug products, which would amend 21 CFR 
    parts 201, 330, and 358 (62 FR 9024, February 27, 1997).
        This public meeting is free of charge; however, space is limited. 
    Registration for the meeting will be accepted in the order received and 
    should be sent to the contact person listed above. Registration should 
    include the name and title of the person attending and the name of the 
    organization being represented, if any.
    
        Dated: May 16, 1997.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 97-13447 Filed 5-21-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
05/22/1997
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice of public meeting.
Document Number:
97-13447
Dates:
The meeting will be held on Thursday, May 29, 1997, from 1:30 p.m. to 4:30 p.m.
Pages:
28053-28053 (1 pages)
PDF File:
97-13447.pdf